Advertisement
ASMB vs NBTX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASMB is a StrongBuy and NBTX is a StrongBuy.
ASMB's RSI Oscillator ascending out of oversold territory
The RSI Indicator for ASMB moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 27 of the 30 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for ASMB just turned positive on October 20, 2026. Looking at past instances where ASMB's MACD turned positive, the stock continued to rise in 31 of 42 cases over the following month. The odds of a continued upward trend are 74%.
Following a +5.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASMB advanced for three days, in 215 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
ASMB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The 10-day moving average for ASMB crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASMB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for ASMB entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. ASMB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.351) is normal, around the industry mean (2.973). P/E Ratio (16.355) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (5.568) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASMB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
NBTX's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for NBTX turned positive on October 20, 2026. Looking at past instances where NBTX's MACD turned positive, the stock continued to rise in 39 of 45 cases over the following month. The odds of a continued upward trend are 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NBTX's RSI Indicator exited the oversold zone, 15 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on NBTX as a result. In 84 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
Following a +20.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where NBTX advanced for three days, in 188 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NBTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
NBTX broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for NBTX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-44.525) is normal, around the industry mean (2.973). P/E Ratio (-26.780) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (48.077) is also within normal values, averaging (438.009).
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. NBTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 67 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NBTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ASMB | NBTX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 6 | 64 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 86 Overvalued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 67 | |
SMR RATING 1..100 | 89 | 99 | |
PRICE GROWTH RATING 1..100 | 79 | 65 | |
P/E GROWTH RATING 1..100 | 96 | 22 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NBTX's Valuation (3) in the null industry is significantly better than the same rating for ASMB (86) in the Pharmaceuticals Other industry. This means that NBTX’s stock grew significantly faster than ASMB’s over the last 12 months.
NBTX's Profit vs Risk Rating (67) in the null industry is somewhat better than the same rating for ASMB (100) in the Pharmaceuticals Other industry. This means that NBTX’s stock grew somewhat faster than ASMB’s over the last 12 months.
ASMB's SMR Rating (89) in the Pharmaceuticals Other industry is in the same range as NBTX (99) in the null industry. This means that ASMB’s stock grew similarly to NBTX’s over the last 12 months.
NBTX's Price Growth Rating (65) in the null industry is in the same range as ASMB (79) in the Pharmaceuticals Other industry. This means that NBTX’s stock grew similarly to ASMB’s over the last 12 months.
NBTX's P/E Growth Rating (22) in the null industry is significantly better than the same rating for ASMB (96) in the Pharmaceuticals Other industry. This means that NBTX’s stock grew significantly faster than ASMB’s over the last 12 months.
| ASMB | NBTX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 79% |
| Stochastic ODDS (%) | 1 day ago 77% | 1 day ago 87% |
| Momentum ODDS (%) | N/A | 1 day ago 83% |
| MACD ODDS (%) | 1 day ago 74% | 1 day ago 87% |
| TrendWeek ODDS (%) | 1 day ago 86% | 1 day ago 81% |
| TrendMonth ODDS (%) | 1 day ago 83% | 1 day ago 80% |
| Advances ODDS (%) | 3 days ago 80% | 1 day ago 81% |
| Declines ODDS (%) | 1 day ago 86% | 4 days ago 82% |
| BollingerBands ODDS (%) | 1 day ago 78% | 1 day ago 88% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASMB’s FA Score shows that 0 FA rating(s) are green while NBTX’s FA Score has 2 green FA rating(s).
- ASMB’s FA Score: 0 green, 5 red.
- NBTX’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASMB’s TA Score shows that 5 TA indicator(s) are bullish while NBTX’s TA Score has 6 bullish TA indicator(s).
- ASMB’s TA Score: 5 bullish, 3 bearish.
- NBTX’s TA Score: 6 bullish, 2 bearish.
Price Growth
ASMB (@Biotechnology) experienced а -0.34% price change this week, while NBTX (@Biotechnology) price change was +21.38% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
Reported Earning Dates
ASMB is expected to report earnings on Nov 09, 2026.
NBTX is expected to report earnings on Nov 17, 2026.
Industries' Descriptions
@Biotechnology (-1.10% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ASMB and
Correlation & Price change
A.I.dvisor indicates that over the last year, ASMB has been loosely correlated with ENTA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ASMB jumps, then ENTA could also see price increases.
| Ticker / NAME | Correlation To ASMB | 1D Price Change % | ||
|---|---|---|---|---|
| ASMB | 100% | -0.88% | ||
| ENTA - ASMB | 43% Loosely correlated | +2.74% | ||
| FDMT - ASMB | 42% Loosely correlated | -6.10% | ||
| VYGR - ASMB | 42% Loosely correlated | -7.92% | ||
| EDIT - ASMB | 41% Loosely correlated | -0.80% | ||
| PRTA - ASMB | 40% Loosely correlated | +2.74% | ||
More | ||||
NBTX and
Correlation & Price change
A.I.dvisor tells us that NBTX and CLLS have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBTX and CLLS's prices will move in lockstep.
| Ticker / NAME | Correlation To NBTX | 1D Price Change % | ||
|---|---|---|---|---|
| NBTX | 100% | +13.01% | ||
| CLLS - NBTX | 31% Poorly correlated | +0.67% | ||
| LKFT - NBTX | 31% Poorly correlated | +2.68% | ||
| ASMB - NBTX | 30% Poorly correlated | -0.88% | ||
| XBIO - NBTX | 30% Poorly correlated | -2.53% | ||
| CGEN - NBTX | 30% Poorly correlated | -7.55% | ||
More | ||||